Akebia Therapeutics Inc (FRA:AX9)
€ 1.072 -0.038 (-3.42%) Market Cap: 286.81 Mil Enterprise Value: 188.98 Mil PE Ratio: 0 PB Ratio: 12.02 GF Score: 55/100

Q1 2026 Akebia Therapeutics Inc Earnings Call Transcript

May 7, 2026 / 12:00 PM GMT
Release Date Price: €1.23 (+1.82%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AKBA.OQ - Akebia Therapeutics Inc
Q1 2026 Akebia Therapeutics Inc Earnings Call
May 07, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and thank you for standing by. Welcome to Acebia's first-quarter 2026 financial results conference call. At this time, all participants are in a listen-only mode.

After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press *11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press *11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Mercedes Carrasco. Please go ahead.

--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot